Balancing curability and unnecessary surgery in the context of computed tomography screening for lung cancer

Objective Surgical management is a critical component of computed tomography (CT) screening for lung cancer. We report the results for US sites in a large ongoing screening program, the International Early Lung Cancer Action Program (I-ELCAP). Methods We identified all patients who underwent surgica...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of thoracic and cardiovascular surgery 2014-05, Vol.147 (5), p.1619-1626
Hauptverfasser: Flores, Raja, MD, Bauer, Thomas, MD, Aye, Ralph, MD, Andaz, Shahriyour, MD, Kohman, Leslie, MD, Sheppard, Barry, MD, Mayfield, William, MD, Thurer, Richard, MD, Smith, Michael, MD, Korst, Robert, MD, Straznicka, Michaela, MD, Grannis, Fred, MD, Pass, Harvey, MD, Connery, Cliff, MD, Yip, Rowena, MPH, Smith, James P., MD, Yankelevitz, David, MD, Henschke, Claudia, PhD, MD, Altorki, Nasser, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1626
container_issue 5
container_start_page 1619
container_title The Journal of thoracic and cardiovascular surgery
container_volume 147
creator Flores, Raja, MD
Bauer, Thomas, MD
Aye, Ralph, MD
Andaz, Shahriyour, MD
Kohman, Leslie, MD
Sheppard, Barry, MD
Mayfield, William, MD
Thurer, Richard, MD
Smith, Michael, MD
Korst, Robert, MD
Straznicka, Michaela, MD
Grannis, Fred, MD
Pass, Harvey, MD
Connery, Cliff, MD
Yip, Rowena, MPH
Smith, James P., MD
Yankelevitz, David, MD
Henschke, Claudia, PhD, MD
Altorki, Nasser, MD
description Objective Surgical management is a critical component of computed tomography (CT) screening for lung cancer. We report the results for US sites in a large ongoing screening program, the International Early Lung Cancer Action Program (I-ELCAP). Methods We identified all patients who underwent surgical resection. We compared the results before (1993-2005) and after (2006-2011) termination of the National Lung Screening Trial to identify emerging trends. Results Among 31,646 baseline and 37,861 annual repeat CT screenings, 492 patients underwent surgical resection; 437 (89%) were diagnosed with lung cancer; 396 (91%) had clinical stage I disease. In the 54 (11%) patients with nonmalignant disease, resection was sublobar in 48 and lobectomy in 6. The estimated cure rate based on the 15-year Kaplan-Meier survival for all 428 patients (excluding 9 typical carcinoids) with lung cancer was 84% (95% confidence interval [CI], 80%-88%) and 88% (95% CI, 83%-92%) for clinical stage I disease resected within 1 month of diagnosis. Video-assisted thoracoscopic surgery and sublobar resection increased significantly, from 10% to 34% ( P  
doi_str_mv 10.1016/j.jtcvs.2013.11.001
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1521340489</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022522313012920</els_id><sourcerecordid>1521340489</sourcerecordid><originalsourceid>FETCH-LOGICAL-c525t-31b70ce2ce3fb50ac8649eb0b86a801e5709be55d9e6fc9d3e80ee39a54a14643</originalsourceid><addsrcrecordid>eNqFkc9u1DAQxi0EotvCEyChHLkkzNhxNjmABBUUpEocAImb5TiTrZfEXmynYt-GZ-HJcNjCgQunuXx_9P2GsScIFQI2z_fVPpnbWHFAUSFWAHiPbRC6bdm08st9tgHgvJScizN2HuMeALaA3UN2xmshOALfsPm1nrQz1u0KswTd28mmY6HdUCzOkaEYdTgWcQk7yte6It1QYbxL9D0Vfvz5w_j5sCQaiuRnvwv6cJPlJhC5NXP0oZiWNTyXUHjEHox6ivT47l6wz2_ffLp8V15_uHp_-eq6NJLLVArst2CIGxJjL0Gbtqk76qFvG90CktxC15OUQ0fNaLpBUAtEotOy1lg3tbhgz065h-C_LRSTmm00NOWp5JeoUHIUNdRtl6XiJDXBxxhoVIdg5zxaIaiVs9qr35zVylkhqsw5u57eFSz9TMNfzx-wWfDiJKA889ZSUNFYygwGG8gkNXj7n4KX__jNZJ01evpKR4p7vwSXCSpUkStQH9dXr59GAcg7DuIX0l-nkg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1521340489</pqid></control><display><type>article</type><title>Balancing curability and unnecessary surgery in the context of computed tomography screening for lung cancer</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Flores, Raja, MD ; Bauer, Thomas, MD ; Aye, Ralph, MD ; Andaz, Shahriyour, MD ; Kohman, Leslie, MD ; Sheppard, Barry, MD ; Mayfield, William, MD ; Thurer, Richard, MD ; Smith, Michael, MD ; Korst, Robert, MD ; Straznicka, Michaela, MD ; Grannis, Fred, MD ; Pass, Harvey, MD ; Connery, Cliff, MD ; Yip, Rowena, MPH ; Smith, James P., MD ; Yankelevitz, David, MD ; Henschke, Claudia, PhD, MD ; Altorki, Nasser, MD</creator><creatorcontrib>Flores, Raja, MD ; Bauer, Thomas, MD ; Aye, Ralph, MD ; Andaz, Shahriyour, MD ; Kohman, Leslie, MD ; Sheppard, Barry, MD ; Mayfield, William, MD ; Thurer, Richard, MD ; Smith, Michael, MD ; Korst, Robert, MD ; Straznicka, Michaela, MD ; Grannis, Fred, MD ; Pass, Harvey, MD ; Connery, Cliff, MD ; Yip, Rowena, MPH ; Smith, James P., MD ; Yankelevitz, David, MD ; Henschke, Claudia, PhD, MD ; Altorki, Nasser, MD ; I-ELCAP Investigators</creatorcontrib><description>Objective Surgical management is a critical component of computed tomography (CT) screening for lung cancer. We report the results for US sites in a large ongoing screening program, the International Early Lung Cancer Action Program (I-ELCAP). Methods We identified all patients who underwent surgical resection. We compared the results before (1993-2005) and after (2006-2011) termination of the National Lung Screening Trial to identify emerging trends. Results Among 31,646 baseline and 37,861 annual repeat CT screenings, 492 patients underwent surgical resection; 437 (89%) were diagnosed with lung cancer; 396 (91%) had clinical stage I disease. In the 54 (11%) patients with nonmalignant disease, resection was sublobar in 48 and lobectomy in 6. The estimated cure rate based on the 15-year Kaplan-Meier survival for all 428 patients (excluding 9 typical carcinoids) with lung cancer was 84% (95% confidence interval [CI], 80%-88%) and 88% (95% CI, 83%-92%) for clinical stage I disease resected within 1 month of diagnosis. Video-assisted thoracoscopic surgery and sublobar resection increased significantly, from 10% to 34% ( P  &lt; .0001) and 22% to 34% ( P  = .01) respectively; there were no significant differences in the percentage of malignant diagnoses (90% vs 87%, P  = .36), clinical stage I (92% vs 89%, P  = .33), pathologic stage I (85% vs 82%, P  = .44), tumor size ( P  = .61), or cell type ( P  = .81). Conclusions The frequency and extent of surgery for nonmalignant disease can be minimized in a CT screening program and provide a high cure rate for those diagnosed with lung cancer and undergoing surgical resection.</description><identifier>ISSN: 0022-5223</identifier><identifier>EISSN: 1097-685X</identifier><identifier>DOI: 10.1016/j.jtcvs.2013.11.001</identifier><identifier>PMID: 24332102</identifier><language>eng</language><publisher>United States: Mosby, Inc</publisher><subject>Aged ; Cardiothoracic Surgery ; Early Detection of Cancer ; Early Medical Intervention ; Female ; Humans ; Kaplan-Meier Estimate ; Lung Neoplasms - diagnostic imaging ; Lung Neoplasms - mortality ; Lung Neoplasms - surgery ; Male ; Mass Screening - methods ; Middle Aged ; Neoplasm Staging ; Patient Selection ; Pneumonectomy - methods ; Predictive Value of Tests ; Prognosis ; Thoracic Surgery, Video-Assisted ; Time Factors ; Tomography, X-Ray Computed ; United States ; Unnecessary Procedures</subject><ispartof>The Journal of thoracic and cardiovascular surgery, 2014-05, Vol.147 (5), p.1619-1626</ispartof><rights>The American Association for Thoracic Surgery</rights><rights>2014 The American Association for Thoracic Surgery</rights><rights>Copyright © 2014 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c525t-31b70ce2ce3fb50ac8649eb0b86a801e5709be55d9e6fc9d3e80ee39a54a14643</citedby><cites>FETCH-LOGICAL-c525t-31b70ce2ce3fb50ac8649eb0b86a801e5709be55d9e6fc9d3e80ee39a54a14643</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0022522313012920$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24332102$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Flores, Raja, MD</creatorcontrib><creatorcontrib>Bauer, Thomas, MD</creatorcontrib><creatorcontrib>Aye, Ralph, MD</creatorcontrib><creatorcontrib>Andaz, Shahriyour, MD</creatorcontrib><creatorcontrib>Kohman, Leslie, MD</creatorcontrib><creatorcontrib>Sheppard, Barry, MD</creatorcontrib><creatorcontrib>Mayfield, William, MD</creatorcontrib><creatorcontrib>Thurer, Richard, MD</creatorcontrib><creatorcontrib>Smith, Michael, MD</creatorcontrib><creatorcontrib>Korst, Robert, MD</creatorcontrib><creatorcontrib>Straznicka, Michaela, MD</creatorcontrib><creatorcontrib>Grannis, Fred, MD</creatorcontrib><creatorcontrib>Pass, Harvey, MD</creatorcontrib><creatorcontrib>Connery, Cliff, MD</creatorcontrib><creatorcontrib>Yip, Rowena, MPH</creatorcontrib><creatorcontrib>Smith, James P., MD</creatorcontrib><creatorcontrib>Yankelevitz, David, MD</creatorcontrib><creatorcontrib>Henschke, Claudia, PhD, MD</creatorcontrib><creatorcontrib>Altorki, Nasser, MD</creatorcontrib><creatorcontrib>I-ELCAP Investigators</creatorcontrib><title>Balancing curability and unnecessary surgery in the context of computed tomography screening for lung cancer</title><title>The Journal of thoracic and cardiovascular surgery</title><addtitle>J Thorac Cardiovasc Surg</addtitle><description>Objective Surgical management is a critical component of computed tomography (CT) screening for lung cancer. We report the results for US sites in a large ongoing screening program, the International Early Lung Cancer Action Program (I-ELCAP). Methods We identified all patients who underwent surgical resection. We compared the results before (1993-2005) and after (2006-2011) termination of the National Lung Screening Trial to identify emerging trends. Results Among 31,646 baseline and 37,861 annual repeat CT screenings, 492 patients underwent surgical resection; 437 (89%) were diagnosed with lung cancer; 396 (91%) had clinical stage I disease. In the 54 (11%) patients with nonmalignant disease, resection was sublobar in 48 and lobectomy in 6. The estimated cure rate based on the 15-year Kaplan-Meier survival for all 428 patients (excluding 9 typical carcinoids) with lung cancer was 84% (95% confidence interval [CI], 80%-88%) and 88% (95% CI, 83%-92%) for clinical stage I disease resected within 1 month of diagnosis. Video-assisted thoracoscopic surgery and sublobar resection increased significantly, from 10% to 34% ( P  &lt; .0001) and 22% to 34% ( P  = .01) respectively; there were no significant differences in the percentage of malignant diagnoses (90% vs 87%, P  = .36), clinical stage I (92% vs 89%, P  = .33), pathologic stage I (85% vs 82%, P  = .44), tumor size ( P  = .61), or cell type ( P  = .81). Conclusions The frequency and extent of surgery for nonmalignant disease can be minimized in a CT screening program and provide a high cure rate for those diagnosed with lung cancer and undergoing surgical resection.</description><subject>Aged</subject><subject>Cardiothoracic Surgery</subject><subject>Early Detection of Cancer</subject><subject>Early Medical Intervention</subject><subject>Female</subject><subject>Humans</subject><subject>Kaplan-Meier Estimate</subject><subject>Lung Neoplasms - diagnostic imaging</subject><subject>Lung Neoplasms - mortality</subject><subject>Lung Neoplasms - surgery</subject><subject>Male</subject><subject>Mass Screening - methods</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Patient Selection</subject><subject>Pneumonectomy - methods</subject><subject>Predictive Value of Tests</subject><subject>Prognosis</subject><subject>Thoracic Surgery, Video-Assisted</subject><subject>Time Factors</subject><subject>Tomography, X-Ray Computed</subject><subject>United States</subject><subject>Unnecessary Procedures</subject><issn>0022-5223</issn><issn>1097-685X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc9u1DAQxi0EotvCEyChHLkkzNhxNjmABBUUpEocAImb5TiTrZfEXmynYt-GZ-HJcNjCgQunuXx_9P2GsScIFQI2z_fVPpnbWHFAUSFWAHiPbRC6bdm08st9tgHgvJScizN2HuMeALaA3UN2xmshOALfsPm1nrQz1u0KswTd28mmY6HdUCzOkaEYdTgWcQk7yte6It1QYbxL9D0Vfvz5w_j5sCQaiuRnvwv6cJPlJhC5NXP0oZiWNTyXUHjEHox6ivT47l6wz2_ffLp8V15_uHp_-eq6NJLLVArst2CIGxJjL0Gbtqk76qFvG90CktxC15OUQ0fNaLpBUAtEotOy1lg3tbhgz065h-C_LRSTmm00NOWp5JeoUHIUNdRtl6XiJDXBxxhoVIdg5zxaIaiVs9qr35zVylkhqsw5u57eFSz9TMNfzx-wWfDiJKA889ZSUNFYygwGG8gkNXj7n4KX__jNZJ01evpKR4p7vwSXCSpUkStQH9dXr59GAcg7DuIX0l-nkg</recordid><startdate>20140501</startdate><enddate>20140501</enddate><creator>Flores, Raja, MD</creator><creator>Bauer, Thomas, MD</creator><creator>Aye, Ralph, MD</creator><creator>Andaz, Shahriyour, MD</creator><creator>Kohman, Leslie, MD</creator><creator>Sheppard, Barry, MD</creator><creator>Mayfield, William, MD</creator><creator>Thurer, Richard, MD</creator><creator>Smith, Michael, MD</creator><creator>Korst, Robert, MD</creator><creator>Straznicka, Michaela, MD</creator><creator>Grannis, Fred, MD</creator><creator>Pass, Harvey, MD</creator><creator>Connery, Cliff, MD</creator><creator>Yip, Rowena, MPH</creator><creator>Smith, James P., MD</creator><creator>Yankelevitz, David, MD</creator><creator>Henschke, Claudia, PhD, MD</creator><creator>Altorki, Nasser, MD</creator><general>Mosby, Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20140501</creationdate><title>Balancing curability and unnecessary surgery in the context of computed tomography screening for lung cancer</title><author>Flores, Raja, MD ; Bauer, Thomas, MD ; Aye, Ralph, MD ; Andaz, Shahriyour, MD ; Kohman, Leslie, MD ; Sheppard, Barry, MD ; Mayfield, William, MD ; Thurer, Richard, MD ; Smith, Michael, MD ; Korst, Robert, MD ; Straznicka, Michaela, MD ; Grannis, Fred, MD ; Pass, Harvey, MD ; Connery, Cliff, MD ; Yip, Rowena, MPH ; Smith, James P., MD ; Yankelevitz, David, MD ; Henschke, Claudia, PhD, MD ; Altorki, Nasser, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c525t-31b70ce2ce3fb50ac8649eb0b86a801e5709be55d9e6fc9d3e80ee39a54a14643</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Aged</topic><topic>Cardiothoracic Surgery</topic><topic>Early Detection of Cancer</topic><topic>Early Medical Intervention</topic><topic>Female</topic><topic>Humans</topic><topic>Kaplan-Meier Estimate</topic><topic>Lung Neoplasms - diagnostic imaging</topic><topic>Lung Neoplasms - mortality</topic><topic>Lung Neoplasms - surgery</topic><topic>Male</topic><topic>Mass Screening - methods</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Patient Selection</topic><topic>Pneumonectomy - methods</topic><topic>Predictive Value of Tests</topic><topic>Prognosis</topic><topic>Thoracic Surgery, Video-Assisted</topic><topic>Time Factors</topic><topic>Tomography, X-Ray Computed</topic><topic>United States</topic><topic>Unnecessary Procedures</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Flores, Raja, MD</creatorcontrib><creatorcontrib>Bauer, Thomas, MD</creatorcontrib><creatorcontrib>Aye, Ralph, MD</creatorcontrib><creatorcontrib>Andaz, Shahriyour, MD</creatorcontrib><creatorcontrib>Kohman, Leslie, MD</creatorcontrib><creatorcontrib>Sheppard, Barry, MD</creatorcontrib><creatorcontrib>Mayfield, William, MD</creatorcontrib><creatorcontrib>Thurer, Richard, MD</creatorcontrib><creatorcontrib>Smith, Michael, MD</creatorcontrib><creatorcontrib>Korst, Robert, MD</creatorcontrib><creatorcontrib>Straznicka, Michaela, MD</creatorcontrib><creatorcontrib>Grannis, Fred, MD</creatorcontrib><creatorcontrib>Pass, Harvey, MD</creatorcontrib><creatorcontrib>Connery, Cliff, MD</creatorcontrib><creatorcontrib>Yip, Rowena, MPH</creatorcontrib><creatorcontrib>Smith, James P., MD</creatorcontrib><creatorcontrib>Yankelevitz, David, MD</creatorcontrib><creatorcontrib>Henschke, Claudia, PhD, MD</creatorcontrib><creatorcontrib>Altorki, Nasser, MD</creatorcontrib><creatorcontrib>I-ELCAP Investigators</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of thoracic and cardiovascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Flores, Raja, MD</au><au>Bauer, Thomas, MD</au><au>Aye, Ralph, MD</au><au>Andaz, Shahriyour, MD</au><au>Kohman, Leslie, MD</au><au>Sheppard, Barry, MD</au><au>Mayfield, William, MD</au><au>Thurer, Richard, MD</au><au>Smith, Michael, MD</au><au>Korst, Robert, MD</au><au>Straznicka, Michaela, MD</au><au>Grannis, Fred, MD</au><au>Pass, Harvey, MD</au><au>Connery, Cliff, MD</au><au>Yip, Rowena, MPH</au><au>Smith, James P., MD</au><au>Yankelevitz, David, MD</au><au>Henschke, Claudia, PhD, MD</au><au>Altorki, Nasser, MD</au><aucorp>I-ELCAP Investigators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Balancing curability and unnecessary surgery in the context of computed tomography screening for lung cancer</atitle><jtitle>The Journal of thoracic and cardiovascular surgery</jtitle><addtitle>J Thorac Cardiovasc Surg</addtitle><date>2014-05-01</date><risdate>2014</risdate><volume>147</volume><issue>5</issue><spage>1619</spage><epage>1626</epage><pages>1619-1626</pages><issn>0022-5223</issn><eissn>1097-685X</eissn><abstract>Objective Surgical management is a critical component of computed tomography (CT) screening for lung cancer. We report the results for US sites in a large ongoing screening program, the International Early Lung Cancer Action Program (I-ELCAP). Methods We identified all patients who underwent surgical resection. We compared the results before (1993-2005) and after (2006-2011) termination of the National Lung Screening Trial to identify emerging trends. Results Among 31,646 baseline and 37,861 annual repeat CT screenings, 492 patients underwent surgical resection; 437 (89%) were diagnosed with lung cancer; 396 (91%) had clinical stage I disease. In the 54 (11%) patients with nonmalignant disease, resection was sublobar in 48 and lobectomy in 6. The estimated cure rate based on the 15-year Kaplan-Meier survival for all 428 patients (excluding 9 typical carcinoids) with lung cancer was 84% (95% confidence interval [CI], 80%-88%) and 88% (95% CI, 83%-92%) for clinical stage I disease resected within 1 month of diagnosis. Video-assisted thoracoscopic surgery and sublobar resection increased significantly, from 10% to 34% ( P  &lt; .0001) and 22% to 34% ( P  = .01) respectively; there were no significant differences in the percentage of malignant diagnoses (90% vs 87%, P  = .36), clinical stage I (92% vs 89%, P  = .33), pathologic stage I (85% vs 82%, P  = .44), tumor size ( P  = .61), or cell type ( P  = .81). Conclusions The frequency and extent of surgery for nonmalignant disease can be minimized in a CT screening program and provide a high cure rate for those diagnosed with lung cancer and undergoing surgical resection.</abstract><cop>United States</cop><pub>Mosby, Inc</pub><pmid>24332102</pmid><doi>10.1016/j.jtcvs.2013.11.001</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-5223
ispartof The Journal of thoracic and cardiovascular surgery, 2014-05, Vol.147 (5), p.1619-1626
issn 0022-5223
1097-685X
language eng
recordid cdi_proquest_miscellaneous_1521340489
source MEDLINE; Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals
subjects Aged
Cardiothoracic Surgery
Early Detection of Cancer
Early Medical Intervention
Female
Humans
Kaplan-Meier Estimate
Lung Neoplasms - diagnostic imaging
Lung Neoplasms - mortality
Lung Neoplasms - surgery
Male
Mass Screening - methods
Middle Aged
Neoplasm Staging
Patient Selection
Pneumonectomy - methods
Predictive Value of Tests
Prognosis
Thoracic Surgery, Video-Assisted
Time Factors
Tomography, X-Ray Computed
United States
Unnecessary Procedures
title Balancing curability and unnecessary surgery in the context of computed tomography screening for lung cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T21%3A10%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Balancing%20curability%20and%20unnecessary%20surgery%20in%20the%20context%20of%C2%A0computed%20tomography%20screening%20for%20lung%20cancer&rft.jtitle=The%20Journal%20of%20thoracic%20and%20cardiovascular%20surgery&rft.au=Flores,%20Raja,%20MD&rft.aucorp=I-ELCAP%20Investigators&rft.date=2014-05-01&rft.volume=147&rft.issue=5&rft.spage=1619&rft.epage=1626&rft.pages=1619-1626&rft.issn=0022-5223&rft.eissn=1097-685X&rft_id=info:doi/10.1016/j.jtcvs.2013.11.001&rft_dat=%3Cproquest_cross%3E1521340489%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1521340489&rft_id=info:pmid/24332102&rft_els_id=S0022522313012920&rfr_iscdi=true